CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-24 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,489 | $53.11 | $238K | 749,230 |
| 2025-06-24 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −15,511 | $53.91 | $836K | 733,719 |
| 2025-06-24 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 316,569 |
| 2025-06-23 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-06-23 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −20,000 | $52.57 | $1.1M | 733,719 |
| 2025-06-23 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 336,569 |
| 2025-06-20 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $8.11 | $162K | 753,719 |
| 2025-06-20 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −20,000 | $52.96 | $1.1M | 733,719 |
| 2025-06-20 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $8.11 | $162K | 356,569 |
| 2025-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise | +5,035 | 33,524 | ||
| 2025-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Shares withheld for taxes | −2,711 | $54.54 | $148K | 30,813 |
| 2025-06-12 | Snyder Mark Howard SVP, CHIEF LEGAL OFFICER | Option exercise · Restricted Stock Units | −5,035 | 15,102 | ||
| 2025-05-01 | Posard Matthew L. Director | Grant or award | +4,165 | 74,039 | ||
| 2025-05-01 | Posard Matthew L. Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | ||
| 2025-05-01 | Miyashita Akiko Moni Director | Grant or award | +4,165 | 24,937 | ||
| 2025-05-01 | Miyashita Akiko Moni Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | ||
| 2025-05-01 | Krishnan Mahesh Director | Grant or award | +4,165 | 10,666 | ||
| 2025-05-01 | Krishnan Mahesh Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 | ||
| 2025-05-01 | Henderson Jeffrey William Director | Grant or award | +4,165 | 32,776 | ||
| 2025-05-01 | Henderson Jeffrey William Director | Grant or award · Option to Purchase Common Stock | +5,750 | 5,750 |
Page 18 of 26 · 513 trades